ACAD logo

ACADIA Pharmaceuticals (ACAD) Current liabilities

annual current liabilities:

$394.87M+$140.62M(+55.31%)
December 31, 2024

Summary

  • As of today (May 18, 2025), ACAD annual total current liabilities is $394.87 million, with the most recent change of +$140.62 million (+55.31%) on December 31, 2024.
  • During the last 3 years, ACAD annual current liabilities has risen by +$298.80 million (+311.03%).
  • ACAD annual current liabilities is now at all-time high.

Performance

ACAD Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADbalance sheet metrics

quarterly current liabilities:

$302.53M-$92.34M(-23.38%)
March 31, 2025

Summary

  • As of today (May 18, 2025), ACAD quarterly total current liabilities is $302.53 million, with the most recent change of -$92.34 million (-23.38%) on March 31, 2025.
  • Over the past year, ACAD quarterly current liabilities has dropped by -$28.07 million (-8.49%).
  • ACAD quarterly current liabilities is now -23.38% below its all-time high of $394.87 million, reached on December 31, 2024.

Performance

ACAD quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

ACAD Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+55.3%-8.5%
3 y3 years+311.0%+152.9%
5 y5 years+427.7%+203.3%

ACAD Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+311.0%-23.4%+159.5%
5 y5-yearat high+427.7%-23.4%+250.1%
alltimeall timeat high+6538.7%-23.4%+5212.2%

ACAD Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$302.53M(-23.4%)
Dec 2024
$394.87M(+55.3%)
$394.87M(+14.8%)
Sep 2024
-
$343.94M(+1.8%)
Jun 2024
-
$337.85M(+2.2%)
Mar 2024
-
$330.60M(+30.0%)
Dec 2023
$254.25M(+102.4%)
$254.25M(+21.3%)
Sep 2023
-
$209.60M(+11.5%)
Jun 2023
-
$187.94M(-16.2%)
Mar 2023
-
$224.30M(+78.5%)
Dec 2022
$125.63M(+30.8%)
$125.63M(+7.8%)
Sep 2022
-
$116.57M(-0.9%)
Jun 2022
-
$117.68M(-1.6%)
Mar 2022
-
$119.60M(+24.5%)
Dec 2021
$96.07M(-9.3%)
$96.07M(+8.9%)
Sep 2021
-
$88.22M(-7.5%)
Jun 2021
-
$95.33M(-12.8%)
Mar 2021
-
$109.37M(+3.2%)
Dec 2020
$105.97M(+41.6%)
$105.97M(+15.4%)
Sep 2020
-
$91.86M(+6.3%)
Jun 2020
-
$86.42M(-13.4%)
Mar 2020
-
$99.74M(+33.3%)
Dec 2019
$74.83M(+25.6%)
$74.83M(+10.5%)
Sep 2019
-
$67.74M(+6.2%)
Jun 2019
-
$63.81M(-14.9%)
Mar 2019
-
$74.98M(+25.9%)
Dec 2018
$59.56M(+21.5%)
$59.56M(+42.5%)
Sep 2018
-
$41.81M(-15.1%)
Jun 2018
-
$49.21M(+6.8%)
Mar 2018
-
$46.09M(-6.0%)
Dec 2017
$49.03M(+15.1%)
$49.03M(+35.7%)
Sep 2017
-
$36.14M(-11.7%)
Jun 2017
-
$40.91M(-9.6%)
Mar 2017
-
$45.27M(+6.3%)
Dec 2016
$42.59M(+94.4%)
$42.59M(+8.8%)
Sep 2016
-
$39.15M(+34.9%)
Jun 2016
-
$29.02M(+37.4%)
Mar 2016
-
$21.12M(-3.6%)
Dec 2015
$21.90M(+38.3%)
$21.90M(+23.5%)
Sep 2015
-
$17.73M(-8.5%)
Jun 2015
-
$19.38M(+16.4%)
Mar 2015
-
$16.65M(+5.2%)
Dec 2014
$15.83M
$15.83M(+40.7%)
Sep 2014
-
$11.25M(+20.5%)
DateAnnualQuarterly
Jun 2014
-
$9.34M(+16.3%)
Mar 2014
-
$8.03M(+15.1%)
Dec 2013
$6.98M(+17.3%)
$6.98M(-11.3%)
Sep 2013
-
$7.87M(+1.2%)
Jun 2013
-
$7.78M(+36.5%)
Mar 2013
-
$5.70M(-4.3%)
Dec 2012
$5.95M(-3.5%)
$5.95M(-2.3%)
Sep 2012
-
$6.09M(-10.0%)
Jun 2012
-
$6.76M(+5.1%)
Mar 2012
-
$6.43M(+4.3%)
Dec 2011
$6.17M(+3.5%)
$6.17M(-3.8%)
Sep 2011
-
$6.41M(+7.8%)
Jun 2011
-
$5.95M(-3.1%)
Mar 2011
-
$6.14M(+3.0%)
Dec 2010
$5.96M(-59.5%)
$5.96M(-54.7%)
Sep 2010
-
$13.17M(+1.4%)
Jun 2010
-
$12.98M(-4.2%)
Mar 2010
-
$13.55M(-7.9%)
Dec 2009
$14.71M(+33.1%)
$14.71M(-3.5%)
Sep 2009
-
$15.25M(-27.2%)
Jun 2009
-
$20.94M(+83.1%)
Mar 2009
-
$11.44M(+3.5%)
Dec 2008
$11.05M(-42.7%)
$11.05M(-1.3%)
Sep 2008
-
$11.20M(-19.3%)
Jun 2008
-
$13.89M(+3.1%)
Mar 2008
-
$13.47M(-30.1%)
Dec 2007
$19.29M(-6.1%)
$19.29M(+12.4%)
Sep 2007
-
$17.16M(+19.7%)
Jun 2007
-
$14.33M(-17.1%)
Mar 2007
-
$17.27M(-15.9%)
Dec 2006
$20.53M(-5.4%)
$20.53M(-1.1%)
Sep 2006
-
$20.77M(-17.9%)
Jun 2006
-
$25.31M(+16.4%)
Mar 2006
-
$21.74M(+0.2%)
Dec 2005
$21.70M(+151.1%)
$21.70M(+10.2%)
Sep 2005
-
$19.69M(+77.7%)
Jun 2005
-
$11.08M(-5.3%)
Mar 2005
-
$11.69M(+35.3%)
Dec 2004
$8.64M(+5.0%)
$8.64M(-7.7%)
Sep 2004
-
$9.36M(-2.1%)
Jun 2004
-
$9.57M(-8.4%)
Mar 2004
-
$10.44M(+26.9%)
Dec 2003
$8.23M(+33.7%)
$8.23M
Dec 2002
$6.15M
-

FAQ

  • What is ACADIA Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual current liabilities year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly current liabilities year-on-year change?

What is ACADIA Pharmaceuticals annual total current liabilities?

The current annual current liabilities of ACAD is $394.87M

What is the all time high annual current liabilities for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual total current liabilities is $394.87M

What is ACADIA Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, ACAD annual total current liabilities has changed by +$140.62M (+55.31%)

What is ACADIA Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of ACAD is $302.53M

What is the all time high quarterly current liabilities for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly total current liabilities is $394.87M

What is ACADIA Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, ACAD quarterly total current liabilities has changed by -$28.07M (-8.49%)
On this page